XML 34 R21.htm IDEA: XBRL DOCUMENT v3.22.1
Business concentrations
12 Months Ended
Dec. 31, 2021
Risks And Uncertainties [Abstract]  
Business concentrations

15.

Business concentrations

We sell our products to wholesale distributors, specialty pharmacies, specialty distributors, and chain drug stores that generally sell products to retail pharmacies, hospitals, and other institutional customers.

Customers with product revenue equal to or greater than 10% of our total revenue for the periods indicated were as follows:

 

 

2021

 

 

2020

 

 

2019

 

Customer A

 

11%

 

 

21%

 

 

37%

 

Customer B

 

15%

 

 

16%

 

 

11%

 

Customer C

 

17%

 

 

28%

 

 

13%

 

Customer E

 

12%

 

 

*

 

 

*

 

Customer F

 

*

 

 

*

 

 

12%

 

* Less than 10% of total product revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

Customers that accounted for 10% or greater of our accounts receivable as of the periods indicated were as follows:

 

 

As of December 31,

 

 

 

2021

 

 

2020

 

Customer A

 

*

 

 

17%

 

Customer B

 

21%

 

 

19%

 

Customer C

 

35%

 

 

25%

 

Customer D

 

11%

 

 

11%

 

* Balance was less than 10% of accounts receivable, gross

 

 

 

 

 

 

 

 

 

We rely on third parties for the manufacture and supply of our products, as well as third-party logistics providers. In instances where these parties fail to perform their obligations, we may be unable to find alternatives suppliers or satisfactorily deliver our products to our customers on time, if at all.

Vendors with product purchases equal to or greater than 10% of our total purchases for the periods indicated were as follows:

 

 

2021

 

 

2020

 

 

2019

 

Catalent

 

33%

 

 

30%

 

 

24%

 

Vendor A

 

36%

 

 

25%

 

 

*

 

Vendor B

 

27%

 

 

36%

 

 

27%

 

Vendor I

 

*

 

 

*

 

 

35%

 

* Less than 10% of total product purchases

 

 

 

 

 

 

 

 

 

 

 

 

 

Vendors that accounted for 10% or greater of our accounts payable as of the periods indicated were as follows:

 

 

As of December 31,

 

 

 

2021

 

 

2020

 

Vendor E

 

19%

 

 

17%

 

Vendor F

 

20%

 

 

16%

 

Vendor G

 

*

 

 

10%

 

* Balance was less than 10% of total accounts payable